Background: Despite strong and consistent associations of elevated LDL-C concentration with coronary artery disease (CAD) incidence, data for incident peripheral artery disease (PAD) are less robust. Atherogenic dyslipidemia characterized by increased LDL particle concentration (LDL-P), hypertriglyceridemia and low HDL-C may be the primary lipid driver of PAD risk. We investigated these issues utilizing both standard lipid measures and NMR-derived lipid subfractions.
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and peak walking time increased significantly in both groups, but significantly more in the exercise group. In the exercise group between visits, quality of life was improved as per the physical component score of the SF-36 questionnaire, and MRI-measured peak perfusion significantly increased in the gastrocnemius muscle and averaged across the leg, and the SvO 2 rate of resaturation (upslope) was significantly increased. Time to peak perfusion in the gastrocnemius muscle was significantly prolonged in the exercise group compared to control group at the follow-up visit.
Conclusion: This study shows that exercise intervention favorably alters vascular function in patients with PAD as expressed in terms of the imaging measures. Generalized estimating equations were used to assess differences in treatment effects over time. PHF is the peak hyperemic flow measured by ASL perfusion, Gastroc the gastrocnemius muscle, AC the anterior compartment, TTP the time to peak. Background: Non-surgical bleeding (NSB) due to angiodysplasia is common in LVAD patients. Thrombininduced Angiopoietin-2 (Ang-2) expression in LVAD patients leads to altered angiogenesis and is associated with lower Angiopoietin-1 (Ang-1) and increased NSB. However, the mechanism for decreased Ang-1, made by pericytes, is unknown and the origin of thrombin in LVAD patients is unclear. We hypothesized that high TNF-α in LVAD patients induces pericyte apoptosis, tissue factor (TF) expression, and vascular instability.
YIA 3

Increased Tumor Necrosis Factor-α Levels in Patients with
Methods:
We incubated cultured pericytes with serum from patients with heart failure (HF), LVAD, or orthotopic heart transplant (OHT) ± TNF-α blockade. We measured Ang-1 expression by RT-PCR and pericyte death by fluorescent stain. We measured TF expression by RT-PCR in cultured endothelial cells incubated with patient plasma ± TNF-α blockade. We measured TF expression in endothelial biopsy samples from these patients by immunofluorescence. We incubated cultured endothelial cells on Matrigel with patient serum ± TNF-α blockade and assessed tube formation by microscopy.
Results: Serum from LVAD patients had higher levels of TNF-α, suppressed Ang-1 expression in pericytes, induced pericyte death, and accelerated endothelial tube formation more so than serum from patients without LVADs. TF was higher in both plasma and endothelial cells from LVAD patients, and plasma from LVAD patients induced more endothelial TF expression. All of these effects were reversed or reduced with TNF-α blockade. All NSB events occurred in LVAD patients with high levels of TNF-α.
Conclusion: Elevated TNF-α in LVAD patients is a central regulator of altered angiogenesis, pericyte apoptosis, and expression of TF and Ang-1. TNF-α blockade may reduce LVAD complications.
YIA 4
Discovery of A Novel Angiogenic Factor TBX20
Shu Meng 1 , John P. Cooke, MD, PhD, MSVM 1 1 Houston Methodist Research Institute, Houston, Texas, USA Background: TBX20 is a crucial transcription factor in development. TBX20 deficiency is associated with congenital heart disease. However, a role of TBX20 in angiogenesis has not been described.
Methods and Results: Transcriptional profiling of heterokaryons composed of murine embryonic stem cells fused with human endothelial cells revealed novel candidate genes mediating endothelial identity, one of which was TBX20. To determine a possible role of TBX20 in endothelial processes, we performed gain-and loss-of-function studies in human umbilical vein endothelial cells (HUVEC). Lentiviral shRNA knockdown (KD) as well as overexpression (OE) using lentiviral constructs encoding the open reading frame of TBX20 were confirmed by RT-PCR and western blot. TBX20 KD significantly impaired endothelial migration and tube formation. Further screening using a PCR array for angiogenic genes revealed PROK2 as a major downstream target of TBX20. The impaired tube formation in TBX20 KD cells could be rescued by PROK2. To determine the role of TBX20 in vivo, we studied subcutaneous matrigel plugs in mice and observed that TBX20 siRNA downregulated PROK2 and blocked angiogenesis. In addition, transient knockdown of TBX20 in zebrafish or TBX20 knockout by CRISPR-CAS9 impaired angiogenesis during development. Overexpression of PROK2 by mRNA rescued the impaired angiogenesis in TBX20 knockdown in zebrafish.
Conclusion: TBX20 is a novel transcription factor regulating adult and embryonic angiogenesis, mediated by PROK2 activation. This pathway may be a therapeutic target in the treatment of diseases characterized by impaired or pathological angiogenesis. Purpose: Previously, we developed non-viral methods to transdifferentiate fibroblasts into induced endothelial cells (iECs) to enhance vascular regeneration. As a glycolytic switch is required for nuclear reprogramming to pluripotency, we hypothesized that a glycolytic switch may also be required for reprogramming fibroblasts to iECs.
YIA 5
A Glycolytic Switch is Required for
Methods and Results:
We used a small molecule-based protocol to transdifferentiate human fibroblasts to endothelial cells. We used Seahorse technology to assess cellular metabolism during transdifferentiation, together with pharmacological and metabolic interventions to assess the role of glycolysis. Within 48 hours of the initiation of the transdifferentiation protocol, human fibroblasts underwent a metabolic switch from oxidative phosphorylation to glycolysis. This switch occurred well before the transformation of fibroblasts into iECs (as assessed by immunohistochemical markers, cellular assays and gene expression). Pharmacological inhibitors of glycolysis impaired the transdifferentiation of fibroblasts into iECs, whereas agents to enhance glycolysis increased the yield both in vitro and in vivo. High glucose conditions impaired glycolysis, as well as iEC generation, an effect which was reversed by antioxidants. Subsequently, we studied this phenomenon in vivo using a model of streptozotocin-induced hyperglycemia mice. Hyperglycemia impaired, whereas administration of the antioxidant NAC restored, the ability of our transdifferentiation cocktail to generate iECs in vivo in a matrigel plug assay.
Conclusion: Our study is the first to show: 1) A glycolytic switch is required for transdifferentiation, 2) Transdifferentiation is impaired by hyperglycemia, 3) Antioxidants can reverse this impairment. These data shed light on a new mechanism for vascular regeneration by transdifferentiation of fibroblasts to endothelial cells. disease (PAD) patients with inducible ischemia by ECG at the low workload of a vascular treadmill test.
Best of SVM Science Rapid Fire Session
Methods: The Mayo Clinic TM-ABI protocol includes a non-graduated speed (2 mph) and ramp (10% grade) for 5 minutes (5 METs) with continuous ECG monitoring. Consecutive patients undergoing TM-ABI (2003 -2006 with inducible ischemia (cases) were age and gender matched (1:2) to contemporary PAD controls without inducible ischemia. Cox regression analysis was used to identify differences in MACE and MALE outcomes between groups.
Results: All PAD patients (170 cases and 340 controls) had a high prevalence of traditional cardiovascular risk factors. During the follow-up period, cases were significantly more likely to undergo coronary revascularization (28% vs 14%; p < 0.001) but significantly less likely to undergo limb revascularization (14% vs 22%; p = 0.03) despite significantly lower post-exercise ABI (0.54 vs 0.66; p = 0.04). In multivariate Cox regression, inducible ischemia was an independent predictor of coronary revascularization and all-cause mortality (Table 1) . Shorter walked distance was an independent predictor of both CV (p = 0.03) and all-cause mortality (p < 0.001).
Conclusion: PAD is a known independent predictor of MACE. In this cohort of PAD patients, ischemia induced by low level TM-ABI testing identifies an even higher risk subset. These data argue for including ECG monitoring during TM-ABI testing for PAD patients. Rhythmic auditory music stimulation (RAS) has been used successfully to reduce pain symptoms and improve walking cadence in patients with neurological gait alterations. The purpose of this study was to test the hypothesis that RAS with increased tempo and bass would increase total walking distance during a 6-minute walk test in patients with claudication compared to music without rhythm enhancement or no music (standard).
Methods: Thirteen patients with claudication (age = 66 ± 8 yrs; ABI, 0.64 +18) underwent three 6-minute walk tests in a random order on the same day. One walk was with music as recorded with the tempo set at the patient's usual walking cadence, one without music, and one with RAS-music with a tempo increase of 10 steps per minute above the patient's usual walking cadence. This increase in tempo is considered imperceptible to the untrained ear.
Results: During the RAS walk patients walked 18.4 ± 22m further than with no music (p = 0.01), and 17 ± 21 m further than with the music without enhancement condition (p = 0.01). The distance walked before stopping due to claudication pain was 38 ± 50 m greater during the RAS condition (p = 0.02), when compared to the nomusic condition. There was a trend for a reduction in perceived claudication pain during the RAS condition (p = 0.09).
Conclusion: These results suggest that RAS immediately increases total walking distance and initial claudication stopping distance in patients with claudication. The immediate increase in walking distance of 18 m is similar to the defined clinically meaningful increase of 20 m for a 6-minute walk test. Background: Elderly patients with acute pulmonary embolism (PE) have higher mortality than nonelderly patients, but receive systemic fibrinolysis less frequently.
Methods: In this analysis of the SEATTLE II trial, we compared the efficacy and safety of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis in patients ≥ 65 years old and those < 65 years old with submassive and massive PE. Eligible patients had proximal PE and a right ventricular (RV)-to-left ventricular (LV) diameter ratio ≥ 0.9 on chest computed tomography (CT). The primary efficacy outcome was the change in chest CT-measured RV/LV diameter ratio at 48 hours after procedure initiation. The primary safety outcome was major bleeding within 72 hours.
Results: Sixty-two patients were ≥ 65 years of age, and 88 were < 65 years of age. RV/LV ratio decreased in both groups 48 hours post-procedure, with a mean change of -0.47 in those ≥ 65 (p < 0.0001) and -0.39 in those < 65 years old (p < 0.0001), with no difference between groups (p = 0.31). Pulmonary artery systolic pressure decreased at 48 hours post-procedure in both groups [-11 .0 mmHg (p < 0.001) in those ≥ 65 and -17.0 mmHg (p < 0.0001) in those < 65 years old; p = 0.053 between groups]. Mean modified Miller Index also decreased in each age group [-7.4 in those ≥ 65 (p < 0.0001) and -6.2 in those < 65 years old (p <0.0001)], with no difference between groups (p = 0.31). Major bleeding occurred in 9 (15%) of those ≥ 65 and in 6 (7%) of those < 65 years old (p = 0.17).
Conclusion: Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis resulted in similar reduction in RV/ LV diameter ratio in elderly patients with massive and submassive PE compared with nonelderly. Background: Endovascular therapy and bypass surgery are both first-line intervention strategies available to clinicians as feasible options for patients with the ischemic limb. The relative merits of these two approaches remain controversial. We report here a meta-analysis combining the evidence from these studies. This is the first meta-analysis to include recent results from the CRITISCH registry, involving contemporary endovascular techniques beyond angioplasty.
Rapid Fire 5
Endovascular Therapy Versus Bypass
Methods: We searched the Pubmed, EMBASE and Cochrane library for pertinent studies that assessed amputation-free survival, mortality, and major amputation as outcomes. We identified 1066 studies, of which 82 were assessed at the full-text level. We excluded 78 articles and analysed the only four studies that assessed amputationfree survival among other outcomes. The Inverse-Variance random effects model was used to generate summary effect estimates for the main end-points of amputation-free survival, mortality, and major amputation.
Results: Four qualifying studies with 2985 patients were meta-analyzed. There was no significant difference in 1-year amputation-free survival between endovascular therapy and bypass surgery groups (OR = 0.97, CI = 0.66-1.42, Figure 1 ). The amputation-free survival at 1 year was 843/1405 (60%) in the endovascular therapy group, versus 781/1580 (49.4%) in the bypass surgery group. Similarly, we found no significant difference in 30-day mortality rate (OR = 0.73, CI = 0.45-1.19), or major amputation (OR = 0.91, CI = 0.61-1.36). The funnel plot suggested no publication bias.
Conclusion: Our results show that endovascular therapy is non-inferior to bypass surgery among patients with critical limb ischemia with regards to the main endpoints of amputation-free survival, major amputation and 30-day mortality. While we await results of ongoing randomized controlled trials, these findings can influence clinician decision-making regarding choice of revascularization procedure in patients with critical limb ischemia. Methods: Inclusion criteria included femoral DVT diagnosed ≥ 6 months earlier, Villalta Score (VS) ≥ 8, and failure of 3 months conservative therapy. Exclusion criteria included high bleeding risk, popliteal vein occlusion and filling defect ≥ 3 cm into the IVC. Patients underwent balloon dilatation of the occlusive DVT segments followed by > 12-h USCDT, then adjunctive therapy as needed. The primary efficacy endpoint was a reduction in VS of ≥ 4 at 30 days post-USCDT in ≥ 50% of patients. The primary safety endpoints were major bleeding events within 72 h of procedure start and pulmonary embolism (PE) within 30 days post-USCDT.
Late-Breaking Oral Presentation
Results: 78 patients (mean age 55, body mass index 32, 68% male) received treatment with USCDT duration of 23 h (± 5.4) and tPA dose of 18.5 mg (± 7.6). Of 77 efficacy evaluable limbs in 73 patients, 67% (p = 0.001; 95% CI = 56%, 77%) met the primary endpoint with the baseline VS improving from 15.8 to 9.8 at 30 days (p < 0.0001; 34% improvement). One (1.3%) major bleed occurred within 72 h post-USCDT procedure. One PE occurred within 30 days of USCDT.
Conclusion: For chronic DVT with PTS patients, endovascular intervention utilizing USCDT with balloon dilatation has been shown to be effective and safe in improving the signs and symptoms of PTS.
Poster Abstracts Basic Science -Angiogenesis/ Vasculogenesis
Poster 1 Background: Lim-domain only (LMO) 2 is a transcription factor that regulates hematopoiesis and vascular remodelling. However, the molecular pathways regulated by LMO2 have not been fully defined. In the present study, we show that LMO2 promotes endothelial cell (EC) migration by modulating Sphingosine Kinase (SPHK) 1, the enzyme that phosphorylates sphingosine to sphingosine-1-phosphate.
LMO2 Promotes Endothelial Cell Migration by SPHK1 Regulation
Methods: LMO2 and SPHK1 knockdown (KD) in vivo was performed by morpholino injection in tg(fli1:gfp) y1 (GFP) zebrafish. LMO2 and SPHK1 modified mRNA were used for rescue. Cell proliferation was analysed by BrdU immunostaining in whole-mounted and enzymatically digested GFP embryos and FACS analysis. In human EC, LMO2, and SPHK1 KD was induced by shRNA. In vitro cell migration was assessed by scratch assay. ChIP-PCR analysis was performed for probing LMO2-SPHK1 interactions. Gene and protein expression were assessed by real time PCR and western blotting.
Results: LMO2 KD reduced intersegmental vessels (ISV) in zebrafish. SPHK1 KD showed a similar, although less extensive, phenotype. The percentage of GFP+ cells in zebrafish were similar in LMO2 KD compared to control. By contrast GFP+ BrdU+ cells were reduced in the ISV. LMO2 KD in human EC reduced LMO2 binding to the promoter region of the SPHK1 gene, reduced SPHK1 expression, and reduced EC migration.
Conclusion: Our data show that LMO2 is necessary for SPHK1 gene expression in endothelial cells. LMO2 KD reduced LMO2 protein-SPHK1 gene interaction, impaired ISV formation, and reduced cell migration. We identified for the first time SPHK1 as downstream effector of LMO2. (Lee et al., Cell, 2012) . Innate immune signaling shifts the balance of epigenetic modifiers to promote an open chromatin configuration required for nuclear reprogramming to pluripotency. We were interested to understand the kinetics of this pathway, as well as the role of iNOS, as it plays a key role in other innate immune responses.
Basic Science -Arterial and Aortic Disease
Methods: Mouse embryonic fibroblasts (MEFs) expressing doxycycline-inducible reprogramming factors Oct4, Sox2, KLF4 and c-Myc were treated with increasing concentrations of the innate immune activator poly I:C, along with doxycycline for 7 and 12 days, respectively. The number of iPSC colonies, and the amount of nitric oxide (NO) generated, were measured in the presence/absence of NO inhibitors or inducible nitric oxide synthase (iNOS)-deficient MEFs. We detected S-nitrosylated nuclear proteins using the Tandem Mass Tag (TMT) switch approach and mass spectroscopy.
Results: PolyI:C dose-dependently increased innate immune signaling as revealed by NFkB luciferase reporter. By contrast, we observed a parabolic response in the generation of iPSCs, with optimal generation in a mid-range of innate immune activation ("Goldilocks zone"). Generation of iPSCs was associated with iNOS induction, NO generation, and increased S-nitrosylation of nuclear proteins, reaching a maximal response in the Goldilocks zone. iPSC generation was markedly reduced by iNOS inhibition and in iNOS-deficient MEFs.
Conclusion: Here we show evidence for an optimal range of innate immune activation in generating iPSCs. Insufficient/excessive innate immune activation impairs nuclear reprogramming. Optimal reprogramming requires iNOS induction and nitrosylation of epigenetic modifiers. Understanding the role of iNOS in nuclear reprogramming is critical for contemporary drug discovery and regenerative medicine efforts for vascular disease. activation was assessed by fluorescence-activated cell sorting (FACS) (surface P-selectin expression) following agonist stimulation for the major platelet signal transduction pathways. Platelet MMP9 content was examined by Western blot, and MMP activity was assessed by zymography.
Results: There was no difference in platelet activation through the P2Y12 receptor in STEMI vs. NSTEMI patients, but platelet activation through the thromboxane receptor and protease-activated receptor 1 (PAR1) signaling pathways was significantly greater in STEMI. Compared to control platelets, only the PAR1 signaling pathway was more activated in STEMI. Platelet MMP9 content was 2-fold more in NSTEMI and 5-fold more in STEMI platelets compared to control. Plasma, platelet, and coronary thrombus MMP9 activity were high in STEMI.
Conclusions: NSTEMI and STEMI show different platelet phenotypes with respect to signaling pathways known to be inhibited by drugs like aspirin and vorapaxar. Platelets from STEMI patients show a marked increase in MMP9 expression compared to NSTEMI. MMP9 activity is enriched in the blood, in platelets, and intracoronary thrombus in STEMI and may be responsible for enhanced platelet activation and adverse cardiac remodeling in this condition. Background: IAC-accredited facilities must meet minimum quality standards and undergo a rigorous evaluation of facility imaging procedures, operations, and organizational structure. The aim of this study is to describe characteristics and accreditation issues of facilities applying for IAC accreditation in vascular testing.
Methods: The IAC database was used to extract characteristics and application findings of all facilities applying for vascular testing accreditation in 2016. Facility total and percentage by demographic characteristic and type of deficiency were reported.
Results: Currently, there are 1634 accredited vascular testing organizations with 2922 sites. Most are accredited in extracranial (1452), venous (1190), and arterial (1157) studies. In 2016, 544 facilities submitted applications of which 10.1% (55/544) applied for the first time. Most were nonhospital-based (61.4%, 334/544). Of medical directors, 51.6% (276/535) were vascular surgeons, 25.6% (137/535) were cardiologists, and 5.0% (27/535) were vascular medicine specialists. Among medical directors, 53.6% (287/535) hold a vascular testing credential (RPVI, 36.3% (194/535) ; RVT, 15.7% (84/535)). The median annual volume of studies per area: extracranial 800 (10-6984), venous 1173 (35-25543), arterial 460 (10-5090). Of those applying, 88.7% (483/544) had deficiencies that had to be rectified before accreditation was granted (Figure 1) . The most frequent issues were incomplete reports (73.5%, 400/544), discrepancies between test documentation and impression (55.7%, 303/544), poor image quality (35.8%, 192/544) , discordance between the impression and the facility's diagnostic criteria, and missed findings (29.2%). Most labs corrected the issues (82.2%, 397/483), with accreditation granted within 90 days.
Conclusion: Accreditation is a process that recognizes a facility as having met minimum quality standards. Although a majority of facilities applying for IAC accreditation must rectify deficiencies, accreditation is granted for most within 90 days. Background: Hutchinson-Gilford progeria syndrome (HGPS) is characterized by accelerated senescence due to a mutation in the LMNA gene. The mutation produces an abnormal lamin A protein called progerin that lacks the splice site necessary to remove a farnesylated domain. Progerin accumulates in the nuclear envelope, disrupting nuclear architecture, chromatin organization, and gene expression. These alterations are associated with rapid telomere erosion and cellular aging. We hypothesized that transfection of Progeria cells with mRNA encoding telomerase (hTERT mRNA) could extend telomeres and reverse senescence.
Methods and Results: Using mmqPCR and telomere-FISH, we found a substantial heterogeneity of average telomere length in fibroblasts derived from HGPS patients. Using fluorescence-activated cell sorting (FACS) and IHC, we also observed that shorter telomeres were associated with low expression of the telomere binding proteins DNA PKcs/Ku70/Ku80. In patients with fibroblasts characterized by short telomeres, transient transfections with hTERT mRNA increased telomere length, expression of telomere binding proteins, and proliferative capacity and cell lifespan and reversed manifestations of cellular senescence (β-galactosidase expression and secretion of inflammatory cytokines). Unexpectedly, mRNA hTERT also reduced the number of cells with nuclear blebbing. In combination with the farnesyltransferase inhibitor lonafarnib (FTI), mmRNA telomerase synergistically promoted HGPS proliferation. Background: Compression therapy is a common form of treatment for chronic venous disorder and lymphedema. Interface pressure is sine qua non to compression therapy. We aimed to evaluate the mechanical performance of three types of sensors in measuring interface pressure.
Conclusion
Methods: The three types of sensors used in this experiment were: 1) Piezoresistive (PZ) sensor: the mechanical principle was described as external pressure was applied, it deformed the PZ sensor membrane and caused decrease in overall resistance which was translated as pressure 2) PicoPress® (Microlab, Padua, Italy) (Pico), manometry based pressure measurement 3)STIFF sensor, a PZ sensor with stiffer membrane. The test was performed on a pressure cuff mannequin model on a silicon foam surface, Rogers® HT800, used for device characterization and comparison. The pressure cuff was controlled by a digital air pump from 20 to 120 mmHg with 20-mmHg increment. Each sensor was subjected to three test runs per reference pressure as described above. Sensor readouts were obtained using analog to digital converters. A paired t-test was used to compare the mean standard deviation (STD) of all three types of sensors.
Results: The mean STD of pressure readouts between the three types of sensors differed significantly, p = 0.0043 (Figure 1) . In all three sensors, the greater the reference pressure, the higher the STD. Pico demonstrated the lowest STD variation while PZ showed the highest variation.
Conclusion: When measuring interface pressure during compression therapy, understanding the mechanical performance of various types of sensor is essential. We demonstrated in all three sensors that the greater the reference pressure, the higher the STD. Picopress® had the least variation in interface pressure measurement.
Clinical Science/EpidemiologyArterial and Aortic Disease
Poster 3 Background: Diagnosis of aortitis is challenging, especially when presentation suggests a ruptured aortic aneurism. Surgical intervention in such cases results in poor outcomes. The aim of this paper is to describe the diagnostic work-up and conservative management of two patients with successfully treated aortitis which was initially diagnosed as raptured abdominal aortic aneurism.
Two Cases of Conservatively Managed Acute Aortitis Presented as Suspected Ruptured
Methods: Retrospective case review.Results: Two patients, a 56-year-old male and a 54-year old female presented to the emergency departments of outside hospitals with acute abdominal pain. Both had an initial diagnosis of suspected raptured abdominal aortic aneurism. Followed by diagnostic work-up, the diagnosis of an acute aortitis was made and confirmed by guided biopsy. Both cases were managed conservatively with favorable outcomes at discharge from the hospital. We describe details of the diagnosis, clinical course, and treatment.
Conclusion: This description of two cases may help in guiding clinical decision making and the differential diagnosis in patients with suspected ruptured aortic aneurism and questionable findings on imaging tests. Methods: PORTRAIT is an international registry that prospectively collected data from 1275 patients with new or worsening PAD. Patients were grouped based on the presence or absence of PVD (PAD + coronary artery disease (CAD) and/or cerebrovascular disease). We compared characteristics at the point of seeking PAD care, including severity of PAD (Rutherford classification (RC)); health status assessed by the Peripheral Artery (PAQ) and EuroQol five dimensions (EQ5D) questionnaires; and subsequent clinical care i.e. statins, antiplatelet agents, supervised exercise (SE), smoking cessation, and revascularization (surgical or endovascular). Continuous variables were compared using Student's t-test. Categorical variables were compared using chisquare or Fisher's exact test.
Poster 9
Differences in Baseline Characteristics
Results: There were 580 patients with and 695 patients without PVD. PVD patients were older (p < 0.001) with higher proportions of men (p = 0.001) and moderate to severe RC (p = 0.01). PAQ summary, social limitation, physical limitation, symptom stability scores as well as EQ5D scores were worse with PVD (see table for p values). Hypertension, chronic kidney disease, and diabetes mellitus were more common with PVD (p < 0.001 for all conditions). SE was prescribed less while statins and anti-platelet therapy were prescribed more with PVD (p < 0.001 for all treatments).
Conclusion: Patients with PAD who have PVD have worse PAD-specific health status at the time of entry into vascular specialty care. In addition, disparities exist in the prescription of PAD risk reduction and QOL improvement therapies. *Non-invasive treatments were assessed after initial visit with PAD specialist and invasive treatments were assessed at 3 months after initial visit with PAD specialist. Data are presented as mean ± SD or n (%).
Poster 10
Long-Term Outcomes and Restenosis Rates After Carotid Artery Stenting of Patients with Prior Neck Irradiation or Surgery
to carotid endarterectomy, including hostile necks (history of neck radiation or surgery). We examined the association of carotid stenting of hostile necks with long-term outcomes and restenosis rates after CAS procedures. Methods: At two institutions, 304 CAS procedures were performed in 268 patients (hostile neck, n = 53; non-hostile neck, n = 215) from 2006-2016. Patients were monitored regularly with duplex carotid ultrasound to assess for target lesion restenosis. A Cox proportional hazard model was developed to determine predictors of restenosis, stroke, and major adverse cardiovascular events.
Results: The mean patient age was 70.1 years. Patients in the hostile neck group were more likely to have a history of smoking, any prior carotid intervention (47% vs. 21%, p < 0.05), and target lesion stenting or CEA (34% vs. 18%, p = 0.01). During a mean follow-up of 1.9 years there were no significant differences in rates of restenosis (36% vs. 29%, p = 0.41), major adverse cardiovascular events (25% vs. 17%, p = 0.24), stroke (7.1% vs. 4%, p = 0.41), or mortality (13% vs. 14%, p = 1.0) between the two groups. In the univariate analysis there was not a statistically significant association between hostile necks and MACE (hazard ratio Conclusion: This retrospective analysis reveals no significant differences in rates of restenosis, MACE, or stroke between patients with hostile vs. non-hostile necks undergoing CAS. This study supports the long-term safety of CAS for patients with hostile necks. Background: Acute aortic emergencies, including dissection and aneurysm rupture, are associated with high morbidity and mortality. Outcome is highly dependent on eliminating delay in diagnosis and treatment. These emergencies are relatively rare and require collaboration among multiple disciplines, representing a unique institutional challenge.
Methods: Physician leadership at our institution identified acute aortic emergencies as an opportunity for a multidisciplinary approach to improve coordination and speed of care. We determined baseline process metrics, implemented a standardized 'code aorta' guideline, and measured our improvement in process variables after 1 year.
Results: At baseline, the mean time from presentation to to initial imaging order was 49 min, the time from imaging result availability to vascular specialist consultation was 78 min, and the overall time from triage to disposition decision (operating room or intensive care unit for aggressive medical management) was 192 min. Over the first year, there were 42 aortic emergencies where a 'code aorta' was activated, and 18 aortic emergencies were 'code aorta' was not activated. Among patients with aortic emergencies where 'code aorta' was activated: mean time from presentation to imaging order improved to 25 min with 78% meeting our pre-specified target of < 25 min; mean time from imaging result to vascular specialist consultation improved to 39 min, a 63% improvement; and mean time from presentation to disposition improved to 96 min, an improvement of over 90 min. Mean times were all significantly better for patients in whom 'code aorta' was activated. 'Code aorta' was activated more consistently and adherence with the guideline improved over time.
Conclusion: These data demonstrate that physician leadership and a multi-disciplinary approach can improve process outcomes in patients with acute aortic emergency. In the future, we would like to determine whether these process improvements translate into expected improvements in outcomes. Background: Re-entry devices (RED) are often used in the endovascular management of common iliac artery (CIA) chronic total occlusions (CTOs) to facilitate procedural success. We examined the impact of RED use on 5-year outcomes including target lesion revascularization (TLR) and major adverse limb events (MALE).
Poster 12
Long-Term Outcomes
Figure 1 (Poster 12).
Methods: We performed a two-center retrospective chart review of 126 patients (139 lesions, RED, n = 43) undergoing CIA CTO endovascular intervention between 2006 and 2016. Baseline characteristics and long-term outcomes (TLR, limb loss, MALE, death) were identified. A Cox proportional hazard model was developed to determine if RED use was associated with TLR or MALE.
Results: The mean age was 63.9 years and the majority (n = 86) of patients were males. Anterograde crossing approach and restenotic lesions were less common in the RED group (10% vs. 33.7%, p < 0.05 and 0% vs. 19.7%, p < 0.05, respectively). There was no significant difference in lesion calcification, Rutherford class, ABI, or patient presentation. The 5-year TLR rate was 28% (27.9% and 28.4%). In the univariate analysis for 5-year outcomes, there was no significant association between RED use and TLR (HR: 0.79; 95% CI: 0.4-1.57; p = 0.51), but the association with MALE had a trend towards statistical significance (HR: 0.51; 95% CI: 0.25-1.03, P = 0.06). Target lesion length was an independent predictor of MALE in both univariate (HR: 1.01; 95% CI: 1-1.02; p < 0.05) andBackground: Spontaneous isolated celiac and mesenteric artery dissection (SICMAD) is an uncommon clinical entity. Little is known about the appropriate treatment and outcomes of SICMAD. Our objective was to compare SICMAD patient outcomes in regards to treatment.
Methods: This was a single center retrospective review. SICMAD was identified through the Massachusetts General Hospital radiology database. Patients who had concomitant aortic dissection or history of trauma were excluded from this analysis as were patients who underwent intervention. SICMAD was confirmed through computed tomography angiography (CTA) or digital subtraction angiography.
Results: Overall 30 patients were identified, 17 with celiac and 13 with mesenteric artery dissection. Of these, 25 were treated with antiplatelet agents and/or anticoagulation while five received no specific treatment (Table 1) . Clinical follow-up was available for 26 (86.7%) patients at a median of 4.3 years (IQR 1.7-7.2 years) and CT follow-up was available for 26 (86.7%) patients at a median of 2.5 years (IQR, 0.2-4.6 years). Complete vascular remodeling was achieved in 3 patients (11.5%), incomplete in 12 (46.2%), and no change on CT follow-up in 11 patients (42.3%). Figure 1 (Poster 14) . Systolic inter-arm pressure differences.
Symptom recurrence occurred in none of the five patients from the non-treatment group, and in 3 (11.5%) on the treatment group (p = 1). One patient in the treatment group died during follow-up for reasons unrelated to the dissection.
Conclusion: In SICMAD patients in whom intervention was not performed, medical treatment did not seem to affect patient outcome. Randomized studies are necessary to confirm these conclusions.
Poster 16
Poster to be presented as novel case report. Background: Invasive imaging such as venography is most frequently used for diagnosis of popliteal vein entrapment. Although less invasive, MRI may be useful, its use for functional entrapment is highly questionable. This study demonstrates the utility of duplex ultrasound for the diagnosis of popliteal vein entrapment syndrome.
Clinical Science/EpidemiologyImaging
Methods: Six symptomatic patients with suspected popliteal vein entrapment syndrome were examined with duplex ultrasound, using volume flow measurements in the proximal femoral vein (FV), profundal femoral vein (PFV) and proximal great saphenous vein (GSV). The contralateral leg served as a control.
Results: At rest in all examined extremities, the dominant flow was via FV, and the flow via PFV or GSV was three to five times lower than the flow via FV. During passive dorsal flexion, in five of the six symptomatic legs, the dominant flow shifted to the PFV (n = 3) or GSV (n = 2). In all contralateral legs of these five patients, FV remained dominant during the maneuver. In one patient, there was no significant flow changes bilaterally. Venography with passive dorsal flexion and active plantar flexion were performed in all six patients, confirming popliteal vein entrapment in five of the six patients who had flow shift on duplex ultrasound.
Conclusion: This small case series demonstrates that duplex ultrasound may be used for initial diagnosis of the popliteal vein entrapment in symptomatic patients. Background: Radiation therapy can alter the morphologic and mechanical properties of the carotid arteries leading to accelerated atherosclerosis and stroke. Carotid intima media thickness (cIMT) and vascular strain (VS) have been suggested as easy-to-use imaging modalities for the early detection of these arterial changes. Our aim was to assess their reproducibility and precision when used by individuals with minimal training. Methods: cIMT, radial (RS), circumferential (CS) and global (GS) strain, were measured in both common carotid arteries in 10 patients undergoing radiation therapy to the neck. The off-line interpretations were performed on the same reading station by three separate readers including a vascular specialist and two unexperienced students with 2 hours of basic training in study processing. The readers were blinded to eachother's findings.
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Results: Using intraclass correlation coefficient (ICC), a measure of inter-and intra-observer variability, cIMT showed excellent agreement between the readers followed by CS (good) and GS (fair). RS was associated with poor agreement (Table 1) . Using the coefficient of inter-observer variability (CIV), a metric of inter-observer variability, CS was associated with the lowest variability (highest agreement, CIV = 0.24).
Conclusion: cIMT followed by CS and GS are associated with good reproducibility and precision irrespective of the degree of the interpreter training. CS has the least inter-observer variability when compared to all other parameters.
well described between obese and non-obese patients. The objective of this secondary analysis of the ELIMIT trial was to determine the association of femoral vein (FV) volume measurements between obese and non-obese PAD subjects.
Methods: FV volumes were quantified with fast spinecho proton density-weighted magnetic resonance imaging (MRI) scans in 79 patients with PAD. Subjects were classified according to their body mass index (BMI) with nonobese<30kg/m 2 , and obese as BMI≥30kg/m 2 .
Results: Baseline characteristics were comparable amongst the patients. As expected, obese patients had a higher prevalence of diabetes mellitus while smoking was more common amongst the non-obese group. Total FV volumes and FV wall volume at baseline were found to be higher in the obese group compared to the non-obese group (p < 0.05; shown in Table1).
Conclusion: Obese individuals with PAD are more likely to be diabetic and have larger FV volumes as compared to non-obese individuals. Future studies will be needed to explore whether increased venous volumes may be a mechanism by which obese patients have a higher incidence of chronic venous insufficiency. , comprised of specialists from cardiology, pulmonology, hematology, interventional radiology, and cardiac surgery was created at our institution. MASCOT offers rapid consultation with a coordinated web-based conference call to discuss patients with high-risk PE. We reviewed patient data collected from MASCOT's registry to describe patient clinical characteristics and outcomes.
Results: From August 2015 through September 2016, there were 72 patients evaluated by MASCOT (Table 1) . Seventy-one had a confirmed PE. Average age was 61 (± 16 years) and 62% were female. PE clinical severity was considered massive in 11 (15%) and submassive in 59 (82%). Systemic fibrinolysis was administered to 8 (11%) patients, and catheter-directed therapy was performed in 13 (18%). Two patients received extracorporeal membrane oxygenation support, and 11 (15%) had an inferior vena cava filter placed. Major bleeding occurred in 9 patients (13%). Overall survival to discharge was 89% (64% in those with massive PE and 93% in those with submassive PE.)
Conclusion: We describe our initial experience with a multidisciplinary, rapid response PE team. PE teams are feasible and offer a patient-centered, coordinated approach to PE management. Further study is warranted to evaluate the impact on patient outcomes of a team-based approach for PE. (Figure 1 ) with edoxaban requires 5 days of initial treatment with a parenteral anticoagulant. This approach poses inconveniences for the patient and often requires hospitalization. Safe dose thrombolysis (SDT) with 50 mg of tPA has been shown to be very effective and safe in the treatment of massive and submassive PE. The effect of edoxaban without 5 days of initial parenteral anticoagulation in patients receiving SDT has not been previously described.
Methods:
We treated 36 patients with PE with edoxaban following SDT. Massive PE was present in 10, submassive in 22 and "low risk" PE in 4 patients. All received SDT 10 mg of tPA in 1 minute followed by 40 mg in 2 hours. A modified dose of heparin was given to all for only 24 hours. Edoxaban at 30 mg daily was given to 28 and 60 mg daily to eight patients. The choice of higher dose edoxaban was empiric (Continued) and based on the extent of thrombus and the weight and size of the patient. Patients were evaluated for death, bleeding, recurrent venous thromboembolism (VTE), duration of hospitalization, changes in pulmonary artery systolic pressure (PASP), right-to-left ventricular (RV/LV) size, and in subjective perception of well being (SPWB) on a 1-5 scale.
Results: The mean follow up was 8 ± 2 months. There were no deaths, bleeding, or recurrent VTE at follow-up. RV/LV and PASP dropped from 1.4 ± 0.3 to 0.8 ± 0.1 and 48 ± 5 to 27 ± 4 mmHg at 6 months respectively (p < 0.05 for both comparisons). The SPWB rose from 2.6 ± 0.4 to 4.5 ± 0.2 at follow-up (p < 0.05). The duration of hospitalization was 40 ± 8 hours.
Conclusion: In patients receiving SDT for PE, edoxaban can be safely and effectively used without the necessity for 5 days of initial parenteral anticoagulation. Its use following SDT obviates the inconveniences associated with 5 days of parenteral anticoagulation and leads to early discharge and marked improvement in clinical and echocardiographic outcomes. Background: Ischemic heart disease is known to increase the risk of strokes. Contemporary data on trends in stroke incidence after acute myocardial infarction (AMI) are scarce. We sought to address these gaps in knowledge, and report on trends in stroke rates in a nationwide cohort of patients hospitalized for AMI from 2007 to 2011.
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Methods: We queried the Nationwide Inpatient Sample (NIS) from 2007 to 2011, using ICD-9-CM codes. Our study population was patients with a primary diagnosis of AMI. In this cohort, we describe baseline characteristics and assessed multi-institutional trends over time in discharge stroke rates. We performed multivariate logistic regression analysis with stroke rates as the primary outcome. This is independent of potential demographic, lifestyle and co-morbid confounders.
Results: Over the study period, a total of 933,828 hospitalizations for AMI were identified. There were 601,105 (64.4%) medicare, 48,952 (5.2%) medicaid, 214,128 (22.9%) private, and 69,643 (7.5%) self-pay patients. Compared to 2007, the risk of having a stroke after AMI was significantly higher in 2011 for Medicare patients (aOR (adjusted odds ratio) = 1.05, 95% CI = 1.00-1.10), the privately insured (aOR = 1.29, CI = 1.16-1.44) and self-pay patients (aOR = 1.21, CI = 1.01-1.44). For patients on Medicaid, however, the risk of post-AMI stroke rose insignificantly in 2009 (aOR = 1.52, CI = 0.88-1.26), then became significant in 2010 (aOR = 1.14, CI = 1.94-1.35), and fell to statistical insignificance by 2011 (aOR = 1.05, CI = 0.93-1.33). See Figure 1 .
Conclusion: The risk of in-hospital stroke after AMI remained high over the study period, for Medicare, privately insured, and self-pay patients. Despite a decreasing trend in overall mortality post-AMI, we report a slowly rising trend in stroke risk following AMI for Medicare, privately insured, and self-pay patients. However, while there was a transiently significant increase in post-AMI stroke risk in 2010, the rise in risk of post-AMI stroke among Medicaid patients was not significant by the end of the study period, in 2011. Further studies are required to understand the factors behind the increasing trends. Background: Stroke is a devastating complication and may occur in higher rate after surgical procedures. Postoperative mortality rate associated with stroke could be as high as 26% compared to 12.6% in non-surgical setting. The incidence of stroke has been well documented after cardiac surgery ranging from 1.4% to 4.3%; however, the risk of post-operative stroke after non-cardiac surgery has not been well investigated in current medical literature. The primary aim of this study was to examine if any correlation between asymptomatic carotid artery stenosis and incidence rate of post-operative stroke may exist and secondarily, to examine if any association between incidence of post-operative stoke and degree of carotid stenosis may exist.
Methods: After institutional review board approval, we retrospectively reviewed database of patients who underwent variety of non-cardiac surgeries or procedures with a known carotid artery stenosis. All individuals had carotid artery ultrasonography revealing variable degree of stenosis detected at least within 2 years prior to surgery. Patients were included only if they underwent a procedure requiring general anesthesia. All carotids were studied by a certified vascular lab technologist using IU 22 Philips Ultrasound units.
Results: We identified 944 carotids in 472 patients (male: 56.1%, female 43.8%). The average age was 71.6 ± 9.8. Of the 472 patients, 324 (68%) were identified with hypertension, 319 with hyperlipidemia (67%), and 187 with diabetes mellitus (39%). Of the 944 carotids, 117 had 60-79% stenosis (53.9% left, 46.1% right), 15 had critical stenosis over 80% (40% left, 60% right), and 16 had total occlusion (37.5% left, 62.5% right). A complete neurological evaluation was performed within 2 weeks after surgery. No statistically significant stroke rate was reported post-operatively in patients with carotid stenosis including those with total carotid occlusion.
Conclusion: Non-cardiac surgery poses no significant risk for post-operative adverse neurological event in patients with extra-cranial carotid artery stenosis. 
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